Ingevity Stock Quote NGVT - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

46.20

Bid

Ask

Volume

129,256

45.28 Day's Range 46.50

36.66 52 Week Range 66.18

Market Cap

1.678B

Previous Close

45.84

Open

46.50

Last Trade

20604

46.2

Last Trade Time

19:00:00

Financial Volume

$ 5,959,675

VWAP

46.1075

Average Volume (3m)

225,091

Shares Outstanding

36,329,455

Dividend Yield

PE Ratio

-311.24

Earnings Per Share (EPS)

-0.15

Revenue

1.69B

Net Profit

-5.4M

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through two segments, namely Performance Chemicals and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of special... Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through two segments, namely Performance Chemicals and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals which find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focusses on automotive carbon products used in automobiles. The Company sells its products worldwide, with special emphasis on North America. Show more

Sector

Chemicals & Allied Products

Industry

Chemicals & Allied Products

Website

www.ingevity.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Ingevity Corporation is listed in the Chemicals & Allied Products sector of the New York Stock Exchange with ticker NGVT. The last closing price for Ingevity was $45.84. Over the last year, Ingevity shares have traded in a share price range of $ 36.66 to $ 66.18.

Ingevity currently has 36,329,455 shares outstanding. The market capitalization of Ingevity is $1.67 billion. Ingevity has a price to earnings ratio (PE ratio) of -311.24.

Ingevity announces dates for second-quarter 2024 earnings release and webcast

Ingevity Corporation (NYSE:NGVT) announced today that it will release its second-quarter 2024 earnings after the stock market close on Wednesday, July 31, 2024. The company will host a live...

Ingevity names new general counsel and chief human resources officer to executive leadership team

Ingevity Corporation (NYSE:NGVT) today announced the appointment of Ryan C. Fisher as senior vice president, general counsel and secretary and Terry Dyer as senior vice president and chief human...

Ingevity partners with Ultrapolymers Group for European sales of Capa® caprolactone Bioplastics

Ingevity Corporation (NYSE:NGVT) today announced the expansion of its Capa® caprolactone distribution network by establishing Ultrapolymers Group as its distributor for Capa Bioplastics in...

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Ingevity releases 2023 sustainability report, details commitment to actions and product innovations that enable a more sustainable world

Ingevity Corporation (NYSE:NGVT) today published its seventh annual Sustainability Report highlighting the advancement of environmental, social and governance sustainability initiatives and...

Form 4 - Statement of changes in beneficial ownership of securities

Ingevity reports first quarter 2024 financial results

HIGHLIGHTS: (comparisons versus prior year period) Net sales of $340.1 million, down 13% primarily as a result of the repositioning of Performance Chemicals Net loss of $56.0 million and diluted...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.23	2.73515677118	44.97	46.63	43.71	181249	45.34050482	CS
4	2.5	5.72082379863	43.7	48.52	40.51	187962	43.99362682	CS
12	-9.16	-16.5462427746	55.36	56.295	40.51	225091	47.20541634	CS
26	1.05	2.32558139535	45.15	56.295	40.51	229344	46.95732606	CS
52	-16.39	-26.1862917399	62.59	66.18	36.66	248447	46.43579018	CS
156	-34.59	-42.8147047902	80.79	90.8	36.66	241675	60.51577521	CS
260	-53.99	-53.8876135343	100.19	102.08	24.92	279353	62.2482646	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CGTXCognition Therapeutics Inc	$ 3.47 (46.41%)	4.6M
NAMSNewAmsterdam Pharma Company NV	$ 22.49 (19.25%)	18.82k
RNAZTransCode Therapeutics Inc	$ 0.341 (15.36%)	6.61M
YYGHYY Group Holding Ltd	$ 0.84 (14.60%)	743
YIBOPlanet Image International Ltd	$ 3.32 (13.89%)	56.73k
VTVTvTv Therapeutics Inc	$ 13.00 (-38.68%)	33.14k
CEROCERo Therapeutics Holdings Inc	$ 0.1669 (-34.80%)	3.51M
TGLTreasure Global Inc	$ 1.32 (-28.65%)	53.49k
LUXHLuxUrban Hotels Inc	$ 0.1587 (-16.91%)	1.31M
RGCRegencell Bioscience Holdings Ltd	$ 10.69 (-13.02%)	14.55k
SLNASelina Hospitality PLC	$ 0.0281 (-6.33%)	23.11M
RNAZTransCode Therapeutics Inc	$ 0.341 (15.36%)	6.61M
CGTXCognition Therapeutics Inc	$ 3.47 (46.41%)	4.6M
TLTiShares 20 plus Year Treasury Bond	$ 92.94 (-0.05%)	3.9M
CEROCERo Therapeutics Holdings Inc	$ 0.1669 (-34.80%)	3.51M